
SAD/MAD studies built for certainty from first dose through cohort review
DVCR supports Single Ascending Dose and Multiple Ascending Dose studies with early phase operational expertise, intensive PK collection, real-time safety oversight and coordinated dose escalation workflows.
Discuss your clinical development program.
This form is for sponsor and CRO partnership inquiries. Share a few details about your upcoming study, and our team will follow up.
Looking to participate in a study? Visit our volunteer website.
A coordinated model for ascending dose study execution
SAD/MAD studies require precise dosing, intensive monitoring, rapid safety review and timely PK visibility between cohorts. DVCR helps sponsors manage the operational complexity of ascending dose studies with experienced clinical, pharmacy, laboratory and data teams working from a coordinated early phase model.
Dose escalation oversight
Experienced teams support cohort progression, rapid safety review and real-time communication workflows between sponsors, investigators and operational leaders.
Dose escalation oversight
Experienced teams support cohort progression, rapid safety review and real-time communication workflows between sponsors, investigators and operational leaders.
Dose escalation oversight
Experienced teams support cohort progression, rapid safety review and real-time communication workflows between sponsors, investigators and operational leaders.
Dose escalation oversight
Experienced teams support cohort progression, rapid safety review and real-time communication workflows between sponsors, investigators and operational leaders.
Dose escalation oversight
Experienced teams support cohort progression, rapid safety review and real-time communication workflows between sponsors, investigators and operational leaders.
Dose escalation oversight
Experienced teams support cohort progression, rapid safety review and real-time communication workflows between sponsors, investigators and operational leaders.
Support for complex ascending dose studies
DVCR supports SAD and MAD studies across healthy volunteer and patient populations, including complex dose-escalation designs, adaptive cohort progression and programs requiring intensive PK/PD collection.
Key capabilities include:
- Single Ascending Dose and Multiple Ascending Dose study execution
- Combined SAD/MAD designs
- Healthy volunteer and patient population studies
- Complex dose escalation and adaptive cohort progression
- Intensive PK/PD sampling schedules
- Rapid safety review workflows
- Real-time sponsor communication and decision support
- Clinical, pharmacy, laboratory and operational coordination